Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026
아시아태평양의 조영제 및 인젝터 시스템 시장 규모는 2022년 19억 8,000만 달러에서 예측 기간 동안 7.24%의 연평균 복합 성장률(CAGR)로 2026년에는 26억 2,000만 달러 규모로 성장할 것으로 예상됩니다. 것으로 예측됩니다.
이 시장은 조영제, 주사기 시스템, 영상 유도 진단에 대한 수요 증가를 가져오는 암 및 심혈관 질환 환자 수 증가 등의 요인에 의해 주도되고 있습니다.
| 주요 시장 통계 |
| 예측 기간 |
2022-2026년 |
| 2022년 평가 |
19억 8,000만 달러 |
| 2026년 전망 |
26억 2,000만 달러 |
| CAGR |
7.24% |
아시아태평양의 조영제 및 인젝터 시스템 시장은 몇 가지 중요한 요인으로 인해 크게 성장하고 있습니다. 첫째, 암, 심혈관 질환 등의 발생률 증가로 인해 조영제 및 인젝터 시스템을 필요로 하는 영상 진단에 대한 수요가 증가하고 있습니다. 이는 특히 정확한 진단과 치료 계획에 필수적입니다.
둘째, 의료용 영상 처리 기술의 발전은 시장 성장을 더욱 촉진하고 있습니다. 혁신적인 조영제 및 인젝터 시스템의 개발로 인해 진단 절차의 정확성과 유효성이 향상되어 의료 서비스 제공업체에게 더욱 친숙하고 신뢰할 수 있는 진단 절차가 가능해졌습니다.
마지막으로, 아시아태평양의 의료 인프라 확대와 의료비 증가가 시장 확대에 기여하고 있습니다. 의료 시설들이 영상 처리 기능을 지속적으로 현대화하고 업그레이드함에 따라 조영제 및 인젝터 시스템에 대한 수요는 이 지역에서 계속 증가할 것으로 예상됩니다.
본 보고서는 아시아태평양의 조영제 및 인젝터 시스템 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 요인 분석, 규제 환경, 특허 동향, 시장 규모 추이 및 예측, 주요 국가별 상세 분석, 주요 기업 분석 등의 정보를 정리하여 전해드립니다.
시장 분류
세분화 1 : 제품별
세분화 : 인젝터 시스템 - 제품별
세분화 2 : 국가별
목차
주요 요약
조사 범위
조사 방법
제1장 시장
- 시장 전망
- 시장 개요
- 업계 전망
- 규제 및 법적 요건과 프레임워크
- 특허 분석
- 주요 동향
- COVID-19가 조영제 및 인젝터 시스템 시장에 미치는 영향
- 시장 역학
- 영향 분석
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
제2장 지역
제3장 시장 : 경쟁 벤치마킹과 기업 개요
- 경쟁 벤치마킹
- 활동적인 조영제 에코시스템 기업
- 기업 개요
- Beijing Beilu Pharmaceutical Co. Ltd.
- FUJIFILM Holdings Corporation
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- Jodas Expoim Pvt. Ltd.
- Shenzen Seacrown Electromechanical Co., Ltd.
- Sino Medical-Device Technology Co., Ltd.
- Unijules Life Sciences Ltd.
LSH
“The Asia-Pacific Contrast Media Agent and Injector System Market Expected to Reach $2.62 Billion by 2026.”
Introduction to Asia-Pacific Contrast Media Agent and Injector System Market
The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.
| KEY MARKET STATISTICS |
|---|
| Forecast Period | 2022 - 2026 |
| 2022 Evaluation | $1.98 Billion |
| 2026 Forecast | $2.62 Billion |
| CAGR | 7.24% |
Market Introduction
The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.
Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.
Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.
Market Segmentation:
Segmentation 1: by Product
- Contrast Media Agents
- Injector Systems
Segmentation: Injector Systems (by Product)
- Injector
- Consumables and Accessories
Segmentation 2: by Country
- China
- Japan
- India
- Australia
- Rest-of-Asia-Pacific
How can this report add value to an organization?
Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.
Key Companies Profiled
- Beijing Beilu Pharmaceutical Co. Ltd.
- FUJIFILM Holdings Corporation
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- Jodas Expoim Pvt. Ltd.
|
- Shenzen Seacrown Electromechanical Co., Ltd.
- Sino Medical-Device Technology Co., Ltd.
- Unijules Life Sciences Ltd.
|
Table of Contents
Executive Summary
Scope of the Study
Research Methodology
1. Markets
- 1.1. Market Outlook
- 1.1.1. Product Definition
- 1.1.2. Inclusion and Exclusion Criteria
- 1.2. Market Overview
- 1.3. Industry Outlook
- 1.3.1. Regulatory and Legal Requirements and Framework
- 1.3.1.1. Regulatory and Legal Requirements and Framework in Asia-Pacific
- 1.3.1.1.1. China
- 1.3.1.1.2. Japan
- 1.3.2. Patent Analysis
- 1.3.2.1. Patent Filing Trend (by Year)
- 1.3.2.2. Patent Filing Trend (by Country)
- 1.3.3. Key Trends
- 1.3.3.1. Nanoparticle-Based Contrast Agents
- 1.3.3.2. Development of Safer Contrast Media Agent
- 1.3.3.3. Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
- 1.4. Impact of COVID-19 on Contrast Media Agent and Injector System Market
- 1.4.1. Pre-COVID-19 Impact
- 1.4.2. During COVID-19 Impact
- 1.4.3. Post-COVID-19 Impact
- 1.5. Market Dynamics
- 1.5.1. Impact Analysis
- 1.5.2. Market Drivers
- 1.5.2.1. Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
- 1.5.2.2. Upsurge in Demand for Image-Guided Diagnostics
- 1.5.2.3. Growing Number of Regulatory Approvals
- 1.5.3. Market Restraints
- 1.5.3.1. Rising Health Concerns Post Usage of Contrast Media Agents in Body
- 1.5.4. Market Opportunities
- 1.5.4.1. IT Advances in Contrast Media Injectors
2. Region
- 2.1. Overview
- 2.2. Asia-Pacific
- 2.2.1. Key Findings
- 2.2.2. Market Dynamics
- 2.2.3. Market Size and Forecast
- 2.2.3.1. Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.1.1. Asia-Pacific Contrast Media Injector System Market (by Product)
- 2.2.3.2. Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
- 2.2.3.2.1. China
- 2.2.3.2.1.1. Market Sizing and Forecast
- 2.2.3.2.1.1.1. China Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.2.1.1.1.1. China Contrast Media Injector System Market (by Product)
- 2.2.3.2.2. Japan
- 2.2.3.2.2.1. Market Sizing and Forecast
- 2.2.3.2.2.1.1. Japan Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.2.2.1.1.1. Japan Contrast Media Injector System Market (by Product)
- 2.2.3.2.3. India
- 2.2.3.2.3.1. Market Sizing and Forecast
- 2.2.3.2.3.1.1. India Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.2.3.1.1.1. India Contrast Media Injector System Market (by Product)
- 2.2.3.2.4. Australia
- 2.2.3.2.4.1. Market Sizing and Forecast
- 2.2.3.2.4.1.1. Australia Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.2.4.1.1.1. Australia Contrast Media Injector System Market (by Product)
- 2.2.3.2.5. Rest-of-Asia-Pacific
- 2.2.3.2.5.1. Market Sizing and Forecast
- 2.2.3.2.5.1.1. Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
- 2.2.3.2.5.1.1.1. Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)
3. Markets - Competitive Benchmarking & Company Profiles
- 3.1. Competitive Benchmarking
- 3.1.1. Key Strategies and Development
- 3.1.1.1. Regulatory and Legal Activities
- 3.1.1.2. Partnerships, Collaborations, and Business Expansions
- 3.1.1.3. Mergers and Acquisitions
- 3.1.1.4. New Offerings
- 3.1.2. Market Share Analysis
- 3.1.2.1. Market Share Analysis, by Contrast Media Agent Market
- 3.1.2.2. Market Share Analysis, by Contrast Media Injector System Market
- 3.2. Contrast Media Ecosystem Active Players
- 3.3. Company Profiles
- 3.3.1. Beijing Beilu Pharmaceutical Co. Ltd.
- 3.3.1.1. Company Overview
- 3.3.1.2. Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.1.3. Recent Developments
- 3.3.1.4. Analyst Perception
- 3.3.2. FUJIFILM Holdings Corporation
- 3.3.2.1. Company Overview
- 3.3.2.2. Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
- 3.3.2.3. Financials
- 3.3.2.4. Analyst Perception
- 3.3.3. Jiangsu Hengrui Pharmaceutical Co., Ltd.
- 3.3.3.1. Company Overview
- 3.3.3.2. Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.3.3. Recent Developments
- 3.3.3.4. Analyst Perception
- 3.3.4. Jodas Expoim Pvt. Ltd.
- 3.3.4.1. Company Overview
- 3.3.4.2. Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.4.3. Analyst Perception
- 3.3.5. Shenzen Seacrown Electromechanical Co., Ltd.
- 3.3.5.1. Company Overview
- 3.3.5.2. Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.5.3. Recent Developments
- 3.3.5.4. Analyst Perception
- 3.3.6. Sino Medical-Device Technology Co., Ltd.
- 3.3.6.1. Company Overview
- 3.3.6.2. Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.6.3. Analyst Perception
- 3.3.7. Unijules Life Sciences Ltd.
- 3.3.7.1. Company Overview
- 3.3.7.2. Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
- 3.3.7.3. Analyst Perception
